<原著>腎細胞癌株におけるinterferon-αの細胞増殖抑制効果に関連する蛋白の網羅的解析

概要

論文の詳細を見る
Interferon-α (IFN) is widely used for the treatment of progressive renal cell carcinoma (RCC), but its effective response rate is only about 15%. New biomarkers of RCC contributing to the effective IFN treatment are needed to establish the sensitivity test if the IFN is effective or not against RCC. All the proteins expressed in the IFN-susceptible and -resistant RCC cell lysates were analyzed by surface enhanced laser desorption inonization (SELDI) mass spectrometry using Protein Chip^[○!R] technology (Ciphergen Biosystems, Fremont, CA), and their different protein expression were detected by the comparison of the profiles between them. We detected the following candidate markers that exhibited peak shifts : (a) in the IFN-susceptible cell lines, a candidate marker with a molecular weight of 5688 Da was detected on a hydrophobic (H4) chip : (b) in the IFN-resistant cell lines, candidate markers with each of molecular weight of 8049, 3157, 3993, and 8959 Da were detected on strong anion exchange (SAX2,pH 9, two types) H4, and weak cation exchange (WCX, pH 9) chips, respectively. IFN treatment produced no weight increase in these four proteins, and (c) candidate marker with a molecular weight of 1623 Da that was expressed in both cell lines after the IFN treatment was detected on the H4 chip. These data suggest that the ProteinChip^[○!R] system is very useful in identifying proteins showing unique peaks in the RCC cell lines with different IFN susceptibility, and the comparison of these proteins measured in RCC cell lysates may help to identify the IFN sensitivity. Furthermore, the discovery of a susceptibility and or a inhibitory factor may eventually lead to the development of a novel drug targeting the respective factor for the improvement of anticancer chemotherapy.
愛知医科大学の論文
2003-03-15

<原著>腎細胞癌株におけるinterferon-αの細胞増殖抑制効果に関連する蛋白の網羅的解析

スポンサーリンク

概要

著者

関連論文

スポンサーリンク